Cargando…
5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112492/ http://dx.doi.org/10.1097/01.HS9.0000928300.84715.89 |
| _version_ | 1785027633793204224 |
|---|---|
| author | Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. |
| author_facet | Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. |
| author_sort | Andemariam, B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10112492 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101124922023-04-19 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. Hemasphere Poster Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112492/ http://dx.doi.org/10.1097/01.HS9.0000928300.84715.89 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Presentations Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_full | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_fullStr | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_full_unstemmed | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_short | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_sort | 5572697 trials in progress: the thrive studies evaluating the efficacy, safety, and long-term treatment with inclacumab, a p-selectin inhibitor, in patients with sickle cell disease |
| topic | Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112492/ http://dx.doi.org/10.1097/01.HS9.0000928300.84715.89 |
| work_keys_str_mv | AT andemariamb 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT inatia 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT colombattir 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT minnitic 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT brownc 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT hottmannm 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT grays 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT hoppec 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT davism 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT yuep 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease |